The DOI matches its Crossref record; 95 of the 95 references it cites were found in a registry or an index.
Leigh syndrome: One disorder, more than 75 monogenic causes
Open accessAbstract
Leigh syndrome is the most common pediatric presentation of mitochondrial disease. This neurodegenerative disorder is genetically heterogeneous, and to date pathogenic mutations in >75 genes have been identified, encoded by 2 genomes (mitochondrial and nuclear). More than one‐third of these disease genes have been characterized in the past 5 years alone, reflecting the significant advances made in understanding its etiological basis. We review the diverse biochemical and genetic etiology of Leigh syndrome and associated clinical, neuroradiological, and metabolic features that can provide clues for diagnosis. We discuss the emergence of genotype–phenotype correlations, insights gleaned into the molecular basis of disease, and available therapeutic options. Ann Neurol 2016;79:190–203
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Braidy, N., Poljak, A., Grant, R., Jayasena, T., Mansour, H., Chan‐Ling, T., Guillemin, G. J., Smythe, G. A., & Sachdev, P. S. (2013) · Biogerontology · doi:10.1007/s10522-013-9489-5 · Cited by 125
RetractedA Mitochondrial Protein Compendium Elucidates Complex I Disease Biology
Pagliarini, D. J., Calvo, S. E., Chang, B., Sheth, S. A., Vafai, S. B., Ong, S.-E., Walford, G. A., Sugiana, C., Boneh, A., Chen, W. K., et al. (2008) · Cell · doi:10.1016/j.cell.2008.06.016 · Cited by 1,994
Self-citationPositron emission tomography study of human brain functional development
Chugani, H. T., Phelps, M. E., & Mazziotta, J. C. (1987) · Annals of Neurology · doi:10.1002/ana.410220408 · Cited by 1,548
SUBACUTE NECROTIZING ENCEPHALOMYELOPATHY IN AN INFANT
Leigh, D. (1951) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.14.3.216 · Cited by 786
Leigh syndrome: Clinical features and biochemical and DNA abnormalities
Rahman, S., Blok, R. B., Dahl, H. ‐. M., Danks, D. M., Kirby, D. M., Chow, C. W., Christodoulou, J., & Thorburn, D. R. (1996) · Annals of Neurology · doi:10.1002/ana.410390311 · Cited by 778
Self-citationBourgeron, T., Rustin, P., Chretien, D., Birch-Machin, M., Bourgeois, M., Viegas-Péquignot, E., Munnich, A., & Rötig, A. (1995) · Nature Genetics · doi:10.1038/ng1095-144 · Cited by 730 · cited 1×
“subunit SDHA were the first nuclear mutations identified to cause OXPHOS disease.(29) Some patients with SDHA”
BackgroundMetabolic costs and evolutionary implications of human brain development
Kuzawa, C. W., Chugani, H. T., Grossman, L. I., Lipovich, L., Muzik, O., Hof, P. R., Wildman, D. E., Sherwood, C. C., Leonard, W. R., & Lange, N. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1323099111 · Cited by 585 · cited 1×
“The metabolic requirements of the brain increase during infancy and peak in early childhood, where it uses glucose at a rate of up to 66% of the body’s resting metabolism.(90) Therefore, it is not surprising that defects in OXPHOS and energy generation can cause early onset neurodegeneration in the form of LS.”
BackgroundIdentification of a gene causing human cytochrome c oxidase deficiency by integrative genomics
Mootha, V. K., Lepage, P., Miller, K., Bunkenborg, J., Reich, M., Hjerrild, M., Delmonte, T., Villeneuve, A., Sladek, R., Xu, F., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.242716699 · Cited by 571
Mitochondrial function and toxicity: Role of the B vitamin family on mitochondrial energy metabolism
Depeint, F., Bruce, W. R., Shangari, N., Mehta, R., & O’Brien, P. J. (2006) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2006.04.014 · Cited by 537
Mitochondrial dysfunction and the inflammatory response
López-Armada, M. J., Riveiro-Naveira, R. R., Vaamonde-García, C., & Valcárcel-Ares, M. N. (2013) · Mitochondrion · doi:10.1016/j.mito.2013.01.003 · Cited by 530
mTOR Inhibition Alleviates Mitochondrial Disease in a Mouse Model of Leigh Syndrome
Johnson, S. C., Yanos, M. E., Kayser, E.-B., Quintana, A., Sangesland, M., Castanza, A., Uhde, L., Hui, J., Wall, V. Z., Gagnidze, A., et al. (2013) · Science · doi:10.1126/science.1244360 · Cited by 512
Treatment for mitochondrial disorders
Pfeffer, G., Majamaa, K., Turnbull, D. M., Thorburn, D., & Chinnery, P. F. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004426.pub3 · Cited by 492
Self-citationTatuch, Y., Christodoulou, J., Feigenbaum, A., Clarke, J. T. R., Wherret, J., Smith, C., Rudd, N., Petrova-Benedict, R., & Robinson, B. H. (1992) · PubMed · Cited by 490
Minimum birth prevalence of mitochondrial respiratory chain disorders in children
Skladal, D. (2003) · Brain · doi:10.1093/brain/awg170 · Cited by 487
Tiranti, V., Viscomi, C., Hildebrandt, T., Di Meo, I., Mineri, R., Tiveron, C., D Levitt, M., Prelle, A., Fagiolari, G., Rimoldi, M., et al. (2009) · Nature Medicine · doi:10.1038/nm.1907 · Cited by 405
López, L. C., Schuelke, M., Quinzii, C. M., Kanki, T., Rodenburg, R. J. T., Naini, A., DiMauro, S., & Hirano, M. (2006) · The American Journal of Human Genetics · doi:10.1086/510023 · Cited by 395
Effective treatment of mitochondrial myopathy by nicotinamide riboside, a vitamin B3
Khan, N. A., Auranen, M., Paetau, I., Pirinen, E., Euro, L., Forsström, S., Pasila, L., Velagapudi, V., Carroll, C. J., Auwerx, J., et al. (2014) · EMBO Molecular Medicine · doi:10.1002/emmm.201403943 · Cited by 385
NAD+-Dependent Activation of Sirt1 Corrects the Phenotype in a Mouse Model of Mitochondrial Disease
Cerutti, R., Pirinen, E., Lamperti, C., Marchet, S., Sauve, A. A., Li, W., Leoni, V., Schon, E. A., Dantzer, F., Auwerx, J., et al. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.04.001 · Cited by 343 · cited 1×
“Drugs such as nicotinamide riboside that can boost NAD synthesis or poly(adenosine diphosphate ribose) polymerase inhibitors that can block NAD degradation are thus promising agents for treating mitochondrial diseases.(107,108) Alleviation of oxidative stress has therefore emerged as a promising avenue of therapy for…”
BackgroundComplex I deficiency: clinical features, biochemistry and molecular genetics
Fassone, E., & Rahman, S. (2012) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2012-101159 · Cited by 320
Self-citationElpeleg, O., Miller, C., Hershkovitz, E., Bitner-Glindzicz, M., Bondi-Rubinstein, G., Rahman, S., Pagnamenta, A., Eshhar, S., & Saada, A. (2005) · The American Journal of Human Genetics · doi:10.1086/430843 · Cited by 314
Self-citationMitochondrial complex I deficiency: from organelle dysfunction to clinical disease
Distelmaier, F., Koopman, W. J. H., van den Heuvel, L. P., Rodenburg, R. J., Mayatepek, E., Willems, P. H. G. M., & Smeitink, J. A. M. (2008) · Brain · doi:10.1093/brain/awp058 · Cited by 310
Quintana, A., Kruse, S. E., Kapur, R. P., Sanz, E., & Palmiter, R. D. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1006214107 · Cited by 279
A guide to diagnosis and treatment of Leigh syndrome
Baertling, F., Rodenburg, R. J., Schaper, J., Smeitink, J. A., Koopman, W. J. H., Mayatepek, E., Morava, E., & Distelmaier, F. (2014) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-304426 · Cited by 279
Metabolic correlates of hominid brain evolution
Leonard, W. R., Robertson, M. L., Snodgrass, J. J., & Kuzawa, C. W. (2003) · Comparative Biochemistry and Physiology Part A: Molecular & Integrative Physiology · doi:10.1016/s1095-6433(03)00132-6 · Cited by 277
A second missense mutation in the mitochondrial ATPase 6 gene in Leigh's syndrome
de Vries, D. D., van Engelen, B. G. M., Gabreëls, F. J. M., Ruitenbeek, W., & van Oost, B. A. (1993) · Annals of Neurology · doi:10.1002/ana.410340319 · Cited by 260
Leigh's Encephalomyelopathy in a Patient With Cytochrome c Oxidase Deficiency in Muscle Tissue
Willems, J. L., Monnens, L. A. H., Trijbels, J. M. F., Veerkamp, J. H., Meyer, A. E. F. H., van Dam, K., & van Haelst, U. (1977) · Pediatrics · doi:10.1542/peds.60.6.850 · Cited by 239
A multicenter study on Leigh syndrome: disease course and predictors of survival
Sofou, K., De Coo, I. F. M., Isohanni, P., Ostergaard, E., Naess, K., De Meirleir, L., Tzoulis, C., Uusimaa, J., De Angst, I. B., Lönnqvist, T., et al. (2014) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-9-52 · Cited by 239
Whole exome sequencing of suspected mitochondrial patients in clinical practice
Wortmann, S. B., Koolen, D. A., Smeitink, J. A., den van Heuvel, L., & Rodenburg, R. J. (2015) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-015-9823-y · Cited by 233
Ghezzi, D., Sevrioukova, I., Invernizzi, F., Lamperti, C., Mora, M., D'Adamo, P., Novara, F., Zuffardi, O., Uziel, G., & Zeviani, M. (2010) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2010.03.002 · Cited by 224
Variant non ketotic hyperglycinemia is caused by mutations in LIAS, BOLA3 and the novel gene GLRX5
Baker, P. R., Friederich, M. W., Swanson, M. A., Shaikh, T., Bhattacharya, K., Scharer, G. H., Aicher, J., Creadon-Swindell, G., Geiger, E., MacLean, K. N., et al. (2014) · Brain · doi:10.1093/brain/awt328 · Cited by 223
Self-citationOpa1 Overexpression Ameliorates the Phenotype of Two Mitochondrial Disease Mouse Models
Civiletto, G., Varanita, T., Cerutti, R., Gorletta, T., Barbaro, S., Marchet, S., Lamperti, C., Viscomi, C., Scorrano, L., & Zeviani, M. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.04.016 · Cited by 216
Biotin-Responsive Basal Ganglia Disease Maps to 2q36.3 and Is Due to Mutations in SLC19A3
Zeng, W.-Q., Al-Yamani, E., Acierno, J. S., Slaugenhaupt, S., Gillis, T., MacDonald, M. E., Ozand, P. T., & Gusella, J. F. (2005) · The American Journal of Human Genetics · doi:10.1086/431216 · Cited by 212
Carrozzo, R., Dionisi-Vici, C., Steuerwald, U., Lucioli, S., Deodato, F., Di Giandomenico, S., Bertini, E., Franke, B., Kluijtmans, L. A. J., Meschini, M. C., et al. (2007) · Brain · doi:10.1093/brain/awl389 · Cited by 208
Wortmann, S. B., Vaz, F. M., Gardeitchik, T., Vissers, L. E. L. M., Renkema, G. H., Schuurs-Hoeijmakers, J. H. M., Kulik, W., Lammens, M., Christin, C., Kluijtmans, L. A. J., et al. (2012) · Nature Genetics · doi:10.1038/ng.2325 · Cited by 208
Patel, K. P., O'Brien, T. W., Subramony, S. H., Shuster, J., & Stacpoole, P. W. (2012) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2012.03.017 · Cited by 192
Mitochondrial encephalomyopathy with elevated methylmalonic acid is caused by SUCLA2 mutations
Ostergaard, E., Hansen, F. J., Sorensen, N., Duno, M., Vissing, J., Larsen, P. L., Faeroe, O., Thorgrimsson, S., Wibrand, F., Christensen, E., et al. (2007) · Brain · doi:10.1093/brain/awl383 · Cited by 188
Choi, W.-S., Palmiter, R. D., & Xia, Z. (2011) · Journal of Cell Biology · doi:10.1083/jcb.201009132 · Cited by 183
Mitochondrial encephalopathies: molecular genetic diagnosis from blood samples
Hammans, S. R., Sweeney, M. G., Brockington, M., Morgan-Hughes, J. A., & Harding, A. E. (1991) · The Lancet · doi:10.1016/0140-6736(91)92981-7 · Cited by 178
Tucker, E. J., Hershman, S. G., Köhrer, C., Belcher-Timme, C. A., Patel, J., Goldberger, O. A., Christodoulou, J., Silberstein, J. M., McKenzie, M., Ryan, M. T., et al. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.07.010 · Cited by 176
Self-citationLeigh Syndrome: Neuropathology and Pathogenesis
Lake, N. J., Bird, M. J., Isohanni, P., & Paetau, A. (2015) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0000000000000195 · Cited by 172
Self-citationAnesthetic considerations in patients with mitochondrial defects
Niezgoda, J., & Morgan, P. G. (2013) · Pediatric Anesthesia · doi:10.1111/pan.12158 · Cited by 167
Viscomi, C. F., Burlina, A., Dweikat, I., Savoiardo, M., Lamperti, C., Hildebrandt, T. M., Tiranti, V., & Zeviani, M. (2010) · Nature Medicine · doi:10.1038/nm.2188 · Cited by 154
Hammans, S. R., Sweeney, M. G., Brockington, M., Lennox, G. G., Lawton, N., Kennedy, C., MORGAN-HUGHES, J. A., & Harding, A. E. (1993) · Brain · doi:10.1093/brain/116.3.617 · Cited by 144
SURF1 deficiency: a multi-centre natural history study
Wedatilake, Y., Brown, R. M., McFarland, R., Yaplito‐Lee, J., Morris, A. A. M., Champion, M., Jardine, P. E., Clarke, A., Thorburn, D. R., Taylor, R. W., et al. (2013) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-8-96 · Cited by 143
Self-citationCoenzyme Q– responsive Leigh's encephalopathy in two sisters
Maldergem, L. V., Trijbels, F. J. M., DiMauro, S., Sindelar, P. J., Musumeci, O., Janssen, A. J. M., Delberghe, X., Martin, J., & Gillerot, Y. (2002) · Annals of Neurology · doi:10.1002/ana.10371 · Cited by 142
ECHS1 mutations in Leigh disease: a new inborn error of metabolism affecting valine metabolism
Peters, H. L., Buck, N. E., Wanders, R. J. A., Ruiter, J. P. N., Waterham, H. R., Koster, J., Yaplito‐Lee, J., Ferdinandusse, S., & Pitt, J. J. (2014) · Brain · doi:10.1093/brain/awu216 · Cited by 139
Pitceathly, R. D. S., Rahman, S., Wedatilake, Y., Polke, J. M., Çırak, S., Foley, A. R., Sailer, A., Hurles, M. E., Stalker, J., Hargreaves, I. P., et al. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.05.005 · Cited by 135
Self-citationDeBrosse, S. D., Okajima, K., Zhang, S., Nakouzi, G. A., Schmotzer, C. L., Lusk, M. M., Frohnapfel, M. B., Grahame, G. J., & Kerr, D. S. (2012) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2012.09.001 · Cited by 128
Mayr, J. A., Freisinger, P., Schlachter, K., Rolinski, B., Zimmermann, F., Scheffner, T., Haack, T. B., Koch, J., Ahting, U., Prokisch, H., et al. (2011) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.11.007 · Cited by 125
Leigh syndrome: serial MR imaging and clinical follow-up.
Arii, J., & Tanabe, Y. (2000) · PubMed · Cited by 125
Neuropathology of mitochondrial diseases
Filosto, M., Tomelleri, G., Tonin, P., Scarpelli, M., Vattemi, G. N. A., Rizzuto, N., Padovani, A., & Simonati, A. (2007) · Bioscience Reports · doi:10.1007/s10540-007-9034-3 · Cited by 123
Debray, F. G., Morin, C., Janvier, A., Villeneuve, J., Maranda, B., Laframboise, R., Lacroix, J., Décarie, J., Robitaille, Y., Lambert, M. A., et al. (2011) · Journal of Medical Genetics · doi:10.1136/jmg.2010.081976 · Cited by 120
Loss of LRPPRC causes ATP synthase deficiency
Mourier, A., Ruzzenente, B., Brandt, T., Kühlbrandt, W., & Larsson, N. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddt652 · Cited by 118
Low mutant load of mitochondrial DNA G13513A mutation can cause Leigh's disease
Kirby, D. M., Boneh, A., Chow, C. W., Ohtake, A., Ryan, M. T., Thyagarajan, D. E., & Thorburn, D. R. (2003) · Annals of Neurology · doi:10.1002/ana.10687 · Cited by 117
Self-citationMitochondrial DNA mutations at nucleotide 8993 show a lack of tissue‐ or age‐related variation
White, S. L., Shanske, S., McGill, J., Mountain, H., Geraghty, M. T., DiMauro, S., Dahl, H. ‐. M., & Thorburn, D. R. (1999) · Journal of Inherited Metabolic Disease · doi:10.1023/a:1005639407166 · Cited by 112
Self-citationSorèze, Y., Boutron, A., Habarou, F., Barnérias, C., Nonnenmacher, L., Delpech, H., Mamoune, A., Chrétien, D., Hubert, L., Bôle‐Feysot, C., et al. (2013) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-8-192 · Cited by 102
Gerards, M., Kamps, R., Vanoevelen, J. M., Boesten, I., Jongen, E., de Koning, B., Scholte, H. R., de Angst, I., Schoonderwoerd, K. C., Sefiani, A., et al. (2013) · Brain · doi:10.1093/brain/awt013 · Cited by 95
Leigh disease associated with a novel mitochondrial DNA ND5 mutation
Taylor, R. W., Morris, A. A. M., Hutchinson, M., & Turnbull, D. M. (2002) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5200773 · Cited by 94
Leigh syndrome, a mitochondrial encephalo(myo)pathy
van Erven, P. M. M., Cillessen, J. P., Eekhoff, E. M. W., Gabreëls, F. J. M., Doesburg, W. H., Lemmens, W. A. J. G., Slooff, J. L., Renier, W. O., & Ruitenbeek, W. (1987) · Clinical Neurology and Neurosurgery · doi:10.1016/s0303-8467(87)80020-3 · Cited by 93
176th ENMC International Workshop: Diagnosis and treatment of coenzyme Q10 deficiency
Rahman, S., Clarke, C. F., & Hirano, M. (2011) · Neuromuscular Disorders · doi:10.1016/j.nmd.2011.05.001 · Cited by 92
Self-citationFerdinandusse, S., Waterham, H. R., Heales, S., Brown, G. K., Hargreaves, I. P., Taanman, J., Gunny, R. S., Abulhoul, L., Wanders, R. J. A., Clayton, P. T., et al. (2013) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-8-188 · Cited by 92
Self-citationLoupatty, F. J., Clayton, P. T., Ruiter, J. P. N., Ofman, R., IJlst, L., Brown, G. K., Thorburn, D. R., Harris, R. A., Durán, M., DeSousa, C., et al. (2006) · The American Journal of Human Genetics · doi:10.1086/510725 · Cited by 91
Self-citationRedox signalling and mitochondrial stress responses; lessons from inborn errors of metabolism
Olsen, R. K. J., Cornelius, N., & Gregersen, N. (2015) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-015-9861-5 · Cited by 83
Next‐generation sequencing for mitochondrial disorders
Carroll, C. J., Brilhante, V., & Suomalainen, A. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12469 · Cited by 77
Succinyl-CoA ligase deficiency: a mitochondrial hepatoencephalomyopathy
Hove, J. V. V., Saenz, M., Thomas, J. A., Gallagher, R., Lovell, M., Fenton, L., Shanske, S., Myers, S., Wanders, R., Ruiter, J., et al. (2010) · Pediatric Research · doi:10.1203/pdr.0b013e3181e5c3a4 · Cited by 74
Lim, S. C., Smith, K. R., Stroud, D. A., Compton, A. G., Tucker, E. J., Dasvarma, A., Gandolfo, L. C., Marum, J. E., McKenzie, M., Peters, H. L., et al. (2014) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2013.12.015 · Cited by 73
Self-citationAssouline, Z., Jambou, M., Rio, M., Bôle‐Feysot, C., de Lonlay, P., Barnérias, C., Desguerre, I., Bonnemains, C., Guillermet, C., Steffann, J., et al. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.01.013 · Cited by 70
A SURF1 gene mutation presenting as isolated leukodystrophy
Rahman, S., Brown, R. M., Chong, W. K., Wilson, C. J., & Brown, G. K. (2001) · Annals of Neurology · doi:10.1002/ana.1060 · Cited by 69
Self-citationWortmann, S. B., Rodenburg, R. J., Huizing, M., Loupatty, F. J., de Koning, T. J., Kluijtmans, L. A. J., Engelke, U. F. H., Wevers, R. A., Smeitink, J. A. M., & Morava, É. (2006) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2006.01.013 · Cited by 68
Haack, T. B., Gorza, M., Danhauser, K., Mayr, J. A., Haberberger, B., Wieland, T., Kremer, L. S., Strecker, V., Graf, E., Memari, Y., et al. (2013) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2013.12.010 · Cited by 67
Analysis of mutant DNA polymerase γ in patients with mitochondrial DNA depletion
Taanman, J., Rahman, S., Pagnamenta, A. T., Morris, A. A. M., Bitner-Glindzicz, M. A. K., Wolf, N. I., Leonard, J. V., Clayton, P. T., & Schapira, A. H. V. (2008) · Human Mutation · doi:10.1002/humu.20852 · Cited by 63
Self-citationRuiter, E. M., Siers, M. H., van den Elzen, C., van Engelen, B. G. M., Smeitink, J. A. M., Rodenburg, R. J., & Hol, F. A. (2006) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201735 · Cited by 61
Phenotypic variability of mitochondrial disease caused by a nuclear mutation in complex II
Pagnamenta, A. T., Hargreaves, I. P., Duncan, A. J., Taanman, J., Heales, S., Land, J. M., Bitner-Glindzicz, M. A. K., Leonard, J. V., & Rahman, S. (2006) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2006.05.003 · Cited by 59
Self-citationMarin, S. E., Mesterman, R., ROBINSON, B. J., Rodenburg, R. J., Smeitink, J. A. M., & Tarnopolsky, M. A. (2012) · Gene · doi:10.1016/j.gene.2012.12.024 · Cited by 59
Late-adult onset Leigh syndrome
McKelvie, P. A., Infeld, B., Marotta, R., Chin, J., Thorburn, D. R., & Collins, S. J. (2012) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2011.09.009 · Cited by 58
Self-citationEarly-Onset Ophthalmoplegia in Leigh-Like Syndrome Due to NDUFV1 Mutations
Laugel, V., This-Bernd, V., Cormier‐Daire, V., Speeg‐Schatz, C., Martin, A. D. S., & Fischbach, M. (2006) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2006.08.007 · Cited by 57
Zhang, Z., Tsukikawa, M., Peng, M., Polyák, E., Nakamaru‐Ogiso, E., Ostrovsky, J., McCormack, S. E., Place, E., Clarke, C., Reiner, G., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069282 · Cited by 56
Biotin Deficiency Inhibits Heme Synthesis and Impairs Mitochondria in Human Lung Fibroblasts
Atamna, H., Newberry, J., Erlitzki, R., Schultz, C. S., & Ames, B. N. (2007) · Journal of Nutrition · doi:10.1093/jn/137.1.25 · Cited by 52
Syndrome of encephalopathy, petechiae, and ethylmalonic aciduria
García‐Silva, M. T., Ribes, A., Campos, Y., Garavaglia, B., & Arenas, J. (1997) · Pediatric Neurology · doi:10.1016/s0887-8994(97)00048-9 · Cited by 50
Santorelli, F. M., Barmada, M. A., Pons, R. M., Zhang, L. L., & DiMauro, S. (1996) · Neurology · doi:10.1212/wnl.47.5.1320 · Cited by 49
Leigh Syndrome in a Girl With a Novel DLD Mutation Causing E3 Deficiency
Quinonez, S. C., Leber, S. M., Martin, D. M., Thoene, J. G., & Bedoyan, J. K. (2013) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2012.09.013 · Cited by 45
Navarro‐Sastre, A., Tort, F., García‐Villoria, J., Pons, M. R., Nascimento, A., Colomer, J., Campistol, J., Yoldi, M. E., López‐Gallardo, E., Montoya, J., et al. (2012) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2012.08.018 · Cited by 43
Neonatal liver failure and Leigh syndrome possibly due to CoQ-responsive OXPHOS deficiency
Leshinsky‐Silver, E., Levine, A., Nissenkorn, A., et al. (2003) · Molecular Genetics and Metabolism · doi:10.1016/s1096-7192(03)00097-0 · Cited by 42
Valayannopoulos, V., Haudry, C., Serre, V., Barth, M., Boddaert, N., Arnoux, J., Cormier-Daire, V., Rio, M., Rabier, D., Vassault, A., et al. (2010) · Mitochondrion (Amsterdam. Print) · doi:10.1016/j.mito.2010.02.006 · Cited by 42
Genetic and biochemical findings in Chinese children with Leigh syndrome
Ma, Y., Wu, T.-F., Liu, Y., Wang, Q., Song, J., Li, X., Shi, X., Zhang, W., Zhao, M. Q., Hu, L., et al. (2013) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2013.03.034 · Cited by 40
Lin, A., Pulliam, D. A., Deepa, S. S., Halloran, J. J., Hussong, S. A., Burbank, R. R., Bresnen, A., Liu, Y., Podlutskaya, N., Soundararajan, A., et al. (2013) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2013.116 · Cited by 38
Emerging aspects of treatment in mitochondrial disorders
Rahman, S. (2015) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-015-9855-3 · Cited by 34
Self-citationIncreased superoxide accumulation in pyruvate dehydrogenase complex deficient fibroblasts
Glushakova, L. G., Judge, S., Cruz, A., Pourang, D., Mathews, C. E., & Stacpoole, P. W. (2011) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2011.07.023 · Cited by 34
Females with PDHA1 gene mutations: A diagnostic challenge
Willemsen, M. H., Rodenburg, R. J., Tészás, A., et al. (2006) · Mitochondrion · doi:10.1016/j.mito.2006.03.001 · Cited by 32
Hernández-Vázquez, A. D. J., Wolf, B., Pindolia, K. R., Ortega-Cuéllar, D., González, R. H., Heredia-Antúnez, A., Ibarra‐González, I., & Velázquez-Arellano, A. (2013) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2013.08.018 · Cited by 28
Scalais, E., François, B., Schlesser, P., Stevens, R., Nuttin, C., Martin, J., Coster, R. V., Seneca, S., Roels, F., Goethem, G. V., et al. (2012) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2012.01.013 · Cited by 26
Yamadori, I., Kurose, A., Kobayashi, S., Ohmori, M., & Imai, T. (1992) · Acta Neuropathologica · doi:10.1007/bf00227830 · Cited by 23
Neuronal and astrocyte dysfunction diverges from embryonic fibroblasts in theNdufs4fky/fkymouse
Bird, M., Wijeyeratne, X. W., Komen, J. C., Laskowski, A., Ryan, M. T., Thorburn, D. R., & Frazier, A. E. (2014) · Bioscience Reports · doi:10.1042/bsr20140151 · Cited by 22
Self-citationMa, Y., Wu, T.-F., Liu, Y., Wang, Q., Li, X., Ding, Y., Song, J., Shi, X., Zhang, W., Zhao, M. Q., et al. (2013) · Brain and Development · doi:10.1016/j.braindev.2013.06.003 · Cited by 19
Salvaging hope: Is increasing NAD+ a key to treating mitochondrial myopathy?
Lightowlers, R. N., & Chrzanowska‐Lightowlers, Z. M. (2014) · EMBO Molecular Medicine · doi:10.15252/emmm.201404179 · Cited by 17
Cited by
Gorman, G. S., Chinnery, P. F., DiMauro, S., Hirano, M., Koga, Y., McFarland, R., Suomalainen, A., Thorburn, D. R., Zeviani, M., & Turnbull, D. M. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.80 · Cited by 1,563
Self-citationMitochondrial dysfunction: mechanisms and advances in therapy
Zong, Y., Li, H., Liao, P., Chen, L., Pan, Y., Zheng, Y., Zhang, C., Liu, D., Zheng, M., & Gao, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01839-8 · Cited by 1,172
A Quantitative Proteome Map of the Human Body
Jiang, L., Wang, M., Lin, S., Jian, R., Li, X., Chan, J., Dong, G., Fang, H., Robinson, A. E., Aguet, F., et al. (2020) · Cell · doi:10.1016/j.cell.2020.08.036 · Cited by 458
Mitochondrial Diseases: Hope for the Future
Russell, O. M., Gorman, G. S., Lightowlers, R. N., & Turnbull, D. M. (2020) · Cell · doi:10.1016/j.cell.2020.02.051 · Cited by 459
Mitochondrial DNA damage and reactive oxygen species in neurodegenerative disease
Nissanka, N., & Moraes, C. T. (2018) · FEBS Letters · doi:10.1002/1873-3468.12956 · Cited by 444
Metadata
- Authors
- Lake, N. J., Compton, A. G., Rahman, S., & Thorburn, D. R.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 2015-12-15
- Volume
- 79
- Issue
- 2
- Pages
- 190-203
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2167627444
- Cited by
- 497
- References
- 95
- FWCI
- 19.90
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.